Viridian Therapeutics Inc (VRDN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,319,093,000
EV to revenue ratio (TTM)
25.13
EV to ebitda
-3.182
Financial Performance
Revenue (TTM)
71,127,000
Gross profit (TTM)
-253,548,992
EBITDA
-404,731,008
Profitability
Operating margin (TTM)
-44,461.00%
Profit margin
0.00%
Return on assets (TTM)
-30.20%
Return on equity (TTM)
-65.70%
Per Share Metrics
Revenue per share (TTM)
0.74
EPS
-3.4
Diluted EPS (TTM)
-3.4
Book value
4.92
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
1.007
PEG ratio
Price to sales ratio (TTM)
32.6
Price to book ratio (TTM)
4.304
Growth
Quarterly earnings growth (YoY)
278.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
14
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.964